METHYLPREDNISOLONE HEMISUCCINATE

DRUG4 trials

Sponsors

Assistance Publique Hopitaux De Paris, AskBio France, BBB-Therapeutics B.V., Beijing Tsinghua Chang Gung Hospital

Conditions

ANCA-associated vasculitisHealthy VolunteersHuntington's diseaseMultiple SclerosisObstructive Sleep ApneaSudden Hearing Loss

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

TerminatedNCT02048358

BBB-Therapeutics B.V.Healthy Volunteers, Multiple Sclerosis

Start: 2013-11-30End: 2015-02-28Updated: 2015-02-06

(ASK-HD-01-CS-101) An Open-Label Phase I/II Dose Finding Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Striatal Administration of AB-1001 in Adult Subjects with Early Manifest Huntington’s Disease (HD)

Active, not recruitingCTIS2024-510895-18-00

AskBio FranceHuntington's disease

Start: 2024-11-07Target: 18Updated: 2025-11-24

Phase 3

A multicenter randomized trial to evaluate the efficacy of pioglitazone to promote renal tolerance in ANCA-associated vasculitis - RENATO

RecruitingCTIS2022-501057-36-00

Assistance Publique Hopitaux De ParisANCA-associated vasculitis

Start: 2023-10-24Target: 126Updated: 2026-01-26

Phase 4

The Effect of PAP on ISSHL Comorbided With OSA

RecruitingNCT04192656

Beijing Tsinghua Chang Gung HospitalObstructive Sleep Apnea, Sudden Hearing Loss

Start: 2019-11-01End: 2029-12-31Target: 102Updated: 2019-12-10